To recognise the International Day of Education, Evie talked to us about neuroscience and her educational journey.
News & views
"I’ve learnt that it’s important to try new things, even if they scare you."
Video courtesy of Meet Delic
Anne Benedict, our Chief People Officer, talks about our approach to creating a workplace that supports mental health.
We've partnered with Ecosia to fund tree-planting projects.
An infographic on this significant milestone.
Our White Paper looks at the state of mental health care in the US, with a focus on treatment-resistant depression.
Our team took part in Plastic Free July, pledging to complete a variety of challenges.
We speak to members of our clinical operations team to find out what it was like to run a clinical trial in the middle of COVID.
We talk to Dr Jason Wallach, Assistant Professor of Pharmaceutical Sciences at USciences, who is leading the work with the COMPASS team.
Psychologist Dr Elizabeth Nielson is a therapist on clinical trials of psilocybin-assisted treatment of alcohol use disorder, MDMA-assisted treatment of PTSD, and psilocybin-assisted treatment of treatment-resistant depression.
We spoke with Scott Aaronson MD, Director of Clinical Research at Sheppard Pratt and The Centre of Excellence about this collaboration with COMPASS.
Dr Manish Agrawal tells us about an innovative investigator-initiated study in cancer patients with depression taking place at The Aquilino Cancer Center.
We've been working with the DBSA to better understand lived experiences of people with depression. We spoke with Phyllis Foxworth and Andrew Smith from the DBSA to learn more.
Three members of our team recently spoke at an event organised by Rocking Ur Teens, a social enterprise in the UK that equips young people with the skills to become leaders.
Here we speak to Archie, the newest member of our learning and development team, about the work we are doing this year to support each team member at COMPASS.
Here Molly and Marco, two COMPASS green ambassadors, tell us what inspires them.
Our highlights in the second half of 2020 as we work towards building a world of mental wellbeing for everyone.
We speak to Laura Arjam, our partner at the Psychiatry Consortium, about her role, the Consortium, and what inspired her to work in mental health.
Researchers from the Grady Trauma Project tell us about their research into mental health care needs and attitudes towards psychedelic therapy in marginalized and underprivileged communities
Meet Lawrence and Archie, the first students to take part in our industrial placement scheme, as they talk about what they hope to achieve over the next year …
We hear from our COMPASS green team about how their plastic-free July challenge went, from their triumphs to their learnings for the future ...
Our team member and intern, Amanda, tells us about her "24 miles in 24 hours challenge" she organised to fund-raise for the crisis in Yemen.
Here are highlights of our activities in the first half of 2020 as we work towards building a world of mental wellbeing for everyone.
We speak to two of our team members about their career journey, decisions they made and advice they have for people about to do the same.
Two members of our COMPASS wellbeing team explain how we are looking after each other's wellbeing, as we continue to work virtually.
We speak to four of our newest team members about their experience of starting a job virtually.
Announcement of our successful $80m Series B investment round completion.
Our green team member, Amy Lawrence, on how planting trees in urban areas could help our mental wellbeing
To recognise World Health Day, we spoke to three lead investigators from our newest trial sites about their reasons for working in mental health and how they see the future.
Letter from our co-founders explaining how we have changed our work to keep people safe during this pandemic.
As we embark on our mentoring journey with The Girls’ Network one of our volunteers, Molly, explains what it takes to be an effective mentor...
Article discussing the granted psilocybin patent. Featuring a comment from co-founder George Goldsmith on what this means for COMPASS Pathways.
To make sure it is safe and effective in patients, psilocybin therapy needs to be approved by medical regulators, not legislators.
The cost of developing psilocybin therapy, with clinical trials in multiple countries, is significant, and involves considerable risk and resource. We think it’s an investment worth making.
Psilocybin therapy is unusual because it’s an innovative protocol that combines a medicine with psychological support.
Here we explain our full commitment to Open Science, including publishing the results from all our trials and supporting the publication of all results from independent studies that use our psilocybin.
Our therapist training programme has been designed by experts from the fields of psychology, psychiatry and psychedelic therapy research.
Here are highlights of our activities in the second half of 2019 that we hope will move us closer to our goal of improving mental health care for as many as possible.
Video courtesy of CNS Summit
An overview of the healthy volunteer study at Kings College London, where COMPASS Pathways COMP360 (psilocybin) was found to be well tolerated.
Here are highlights of our activities in the first half of 2019 that we hope will move us closer to our goal of improving mental health care for as many as possible.
As 2018 draws to a close, we reflect on another busy year and share our highlights of the last few months with you.
Article written for the MAPS Bulletin Winter 2018. By Ekaterina Malievskaia, MD, MSc
COMPASS Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health ...
This is the second of regular newsletters from COMPASS, highlighting recent and forthcoming events and developments that are relevant to us, our partners and healthcare system stakeholders.
The holiday season is approaching, and as we begin dreaming of festive treats and spending the holidays cocooned in thick duvets with a cup of hot chocolate in hand, I would like to reflect on our journey this past year and share a few 2017 highlights.